Panagora Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Panagora Asset Management’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,324	Closed	-$126K	–	3033
2021 Q1	$126K	Buy	25,324 +1,211	+5%	+$9.79K	﹤0.01%	1876
2020 Q4	$305K	Buy	24,113 +4,751	+25%	+$54.2K	﹤0.01%	1416
2020 Q3	$190K	Sell	19,362 -10,163	-34%	-$100K	﹤0.01%	1533
2020 Q2	$294K	Sell	29,525 -27,039	-48%	-$259K	﹤0.01%	1387
2020 Q1	$500K	Sell	56,564 -170,836	-75%	-$1.68M	﹤0.01%	1124
2019 Q4	$2.1M	Buy	227,400 +27,191	+14%	+$193K	0.01%	770
2019 Q3	$1.18M	Sell	200,209 -33,135	-14%	-$352K	0.01%	953
2019 Q2	$2.8M	Buy	233,344 +101,152	+77%	+$1.09M	0.01%	694
2019 Q1	$1.6M	Buy	132,192 +8,687	+7%	+$128K	0.01%	925
2018 Q4	$1.55M	Sell	123,505 -29,313	-19%	-$405K	0.01%	885
2018 Q3	$2.27M	Sell	152,818 -81,288	-35%	-$1.28M	0.01%	790
2018 Q2	$3.94M	Buy	234,106 +114,905	+96%	+$2.23M	0.02%	618
2018 Q1	$2.73M	Buy	119,201 +81,981	+220%	+$1.82M	0.01%	756
2017 Q4	$963K	Buy	+37,220	New	+$749K	﹤0.01%	1151
2015 Q4	–	Sell	-3,088	Closed	-$58K	–	2391
2015 Q3	$58K	Sell	3,088 -15,915	-84%	-$270K	﹤0.01%	1958
2015 Q2	$283K	Sell	19,003 -13,655	-42%	-$208K	﹤0.01%	1532
2015 Q1	$495K	Buy	+32,658	New	+$456K	﹤0.01%	1318

Other funds holding CNCE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Panagora Asset Management's CNCE Position: Q2 2021 in Review

Panagora Asset Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 25,324 shares — an estimated $126K sold.

Panagora Asset Management first reported a position in CNCE in Q1 2015 and held it in 17 quarters. The position peaked at $3.94M in Q2 2018. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

Panagora Asset Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Panagora Asset Management sold 25,324 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $126K.
Panagora Asset Management first reported a position in Concert Pharmaceuticals, Inc. in Q1 2015 and held it in 17 quarters.
Panagora Asset Management's Concert Pharmaceuticals, Inc. position peaked at $3.94M in Q2 2018.
79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.